Emicizumab for acquired haemophilia A: A case series.
Matthias M EngelenJohan VandesandeJohan De BentChristine Van LaerVeerle LabarqueMarc JacqueminKathelijne PeerlinckCedric HermansPeter VerhammeThomas VanasschePublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2023)
In this AHA case series, no new clinically relevant bleeds were observed after initiation of emicizumab in conjunction with standard immunosuppressive therapy.
Keyphrases